share_log

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyssikatos Joseph P

SEC ·  Oct 11 08:40
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more